Sucampo Announces Resolution of Par Pharmaceutical's ANDA for RESCULA(R)
11 févr. 2015 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Feb. 11, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Sucampo and R-Tech Ueno, Ltd. (RTU),...